Dosing & Uses
Dosage Forms & Strengths
polyethylene glycol/electrolytes/sodium ascorbate/ascorbic acid
oral powder for solution
- After reconstitution (of 4 packets/2L) contains Pouch A (100g PEG 3350, 7.5 g sodium sulfate, 2.69g sodium chloride, 1.015 g potassium chloride), and Pouch B (4.7 g ascorbic acid, and 5.9 g sodium ascorbate)
Four separate pouches in kit (2 of pouch A and 2 of pouch B)
1 pouch A and 1 pouch B are dissolved together in water to a volume of 1 L for oral use
Cleansing of the colon as preparation for colonoscopy in 18 yrs and older: 2 L PO prior to colonoscopy
- Evening before colonoscopy: 1 L PO over 1 hr (240 mL q 15 min)
- Follow with 0.5 L (480mL) clear fluid
- Morning of colonoscopy: At least 3.5 hr before colonoscopy, drink 1 L PO over 1 hr (240 mL q 15 min)
- Follow with 0.5 L (480mL) clear fluid at least 1 hr prior to colonoscopy
- 6 PM the evening before colonoscopy: 1 L PO over 1 hr (240 mL q 15 min)
- Approximately 1.5 hrs later, 1 L PO over 1 hr (240 mL q 15 min)
- Follow with 1 L additional clear liquid during the evening before colonoscopy
Pharmacokinetics have not been studied in patients with renal or hepatic insufficiency
PEG/electrolyte Solution Preparation
- Prepare solution by emptying contents of 1 pouch A and 1 pouch B into a suitable glass container (or the container provided) and adding to the container 1 L lukewarm water
- Mix the solution to ensure that the ingredients are completely dissolved
- Solution can be refrigerated prior to drinking
- Reconstituted solution should be used within 24 hours
- After consumption of the first liter of solution, the above mixing procedure should be repeated with the second pouch A and pouch B to reconstitute the second liter
- No additional ingredients (eg, flavorings) should be added to the solution
Safety and efficacy not established in pediatrics
- Malaise (18-27%)
- Nausea (14-47%)
- Abdominal pain (13-39%)
- Vomiting (17 -12%)
- Abdominal distension (59.8%)
- Anal discomfort (51.5%)
- Thirst, nausea (47.3%)
- Abdominal pain (39.1%)
- Sleep disorder (34.9%)
- Rigors (33.7%)
- Hunger (30.2%)
- Malaise (26.6%)
- Vomiting (7.8%)
- Upper abdominal pain (5.6%)
- Dyspepsia (2.8%)
- Vomiting (7.1%)
- Dizziness (6.5%)
- Headache (1.8%)
Frequency Not Defined
Cardiovascular: Tachycardia, palpitations, hypertension, arrhythmia, atrial fibrillation, peripheral edema
General: Hypersensitivity reactions including anaphylaxis (some of which were severe, including shock), rash, urticaria, pruritus, lip, tongue and facial swelling, dyspnea, chest tightness and throat tightness; fever, chills, and dehydration
Nervous system: Syncope, tremor, seizure
Renal: Renal impairment and/or failure
Use with caution in patients using concomitant medications that increase the risk of electrolyte abnormalities
Use with caution in patients with severe ulcerative colitis, ileus, gastrointestinal obstruction
Patients with impaired gag reflex and patients prone to regurgitation or aspiration should be observed during the administration
Since product contains sodium ascorbate and ascorbic acid, use with caution in patients with glucose-6-phosphate dehydrogenase (G-6-PD) deficiency
If severe vomiting occurs, check serum electrolytes
Phenylketonurics: product contains phenylalanine
Serious arrythmias reported
Pregnancy & Lactation
Pregnancy Category: C
Lactation: Unknown whether distributed in breast milk, caution advised
A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA:Information not available.
Mechanism of Action
Elicits osmotic laxative effect and replenishes electrolytes; induces catharsis through strong electrolyte and osmotic effects
Onset: 1-2 hr
Adding plans allows you to compare formulary status to other drugs in the same class.
To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.
Adding plans allows you to:
- View the formulary and any restrictions for each plan.
- Manage and view all your plans together – even plans in different states.
- Compare formulary status to other drugs in the same class.
- Access your plan list on any device – mobile or desktop.
The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.
|1||This drug is available at the lowest co-pay. Most commonly, these are generic drugs.|
|2||This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.|
|3||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.|
|4||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|5||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|6||This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.|
|NC||NOT COVERED – Drugs that are not covered by the plan.|
Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.